Eastman Chemical Company

Valuation Analysis

About the Company

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids. It serves transportation, personal care, wellness, food, feed, agriculture, building and construction, water treatment, energy, consumables, durables, and electronics markets. Its Advanced Materials segment provides copolyesters, cellulosic biopolymers, polyvinyl butyral sheets, polyester films and window and protective films for value-added end uses in the transportation

Eastman Chemical Company Stock at a Glance

Eastman Chemical Company (EMN) is currently trading at $75.22 with a market capitalization of $8.6B. The trailing P/E ratio stands at 21.74x, with a forward P/E of 10.73x. The 52-week range spans from $56.11 to $83.47; the current price is 9.9% below the yearly high. Year-over-year revenue growth stands at -4.9%. The net profit margin stands at 4.62%.

💰 Dividend

Eastman Chemical Company pays an annual dividend of $3.36 per share, representing a yield of 4.47%. The payout ratio stands at 96.53%. The elevated payout ratio reflects a mature dividend policy.

📊 Analyst Rating

15 analysts rate Eastman Chemical Company (EMN) on consensus: None. The average price target is $84.33, implying +12.12% from the current price. Analyst price targets range from $74.00 to $100.00.

Eastman Chemical Company: The Investment Case in Detail

Eastman Chemical Company (EMN) operates in the Basic Materials — specifically Specialty Chemicals — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bear Case

Revenue is contracting at -4.9% year-over-year — until that trend reverses, valuation is exposed to further downgrades. With a net margin of just 4.62%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

Valuation in Context

With a PEG ratio of 0.64, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 9.83x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

What to Watch Next

• The forward P/E of 10.73x is meaningfully below the trailing 21.74x — analysts expect earnings to step up; the next earnings release is the test.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to market-like volatility, elevated short interest (6.45%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Eastman Chemical Company?

Compare top-rated brokers — low fees, trusted providers, fully regulated.